2
Views
10
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Pituitary Pro-Opiomelanocortin Gene Expression Requires Synergistic Interactions of Several Regulatory Elements

&
Pages 3492-3503 | Received 06 Dec 1990, Accepted 26 Apr 1991, Published online: 31 Mar 2023

REFERENCES

  • Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
  • Barberis, A., G. Superti-Furga, and M. Busslinger. 1987. Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter. Cell 50:347-359.
  • Bodner, M., J.-L. Castrillo, L. E. Theill, T. Deerinck, M. Ellisman, and M. Karin. 1988. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55:505-518.
  • Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
  • Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoterspecific transcription factor Sp1. Science 234:47-52.
  • Catanzaro, D. F., B. L. West, J. D. Baxter, and T. L. Reudelhuber. 1987. A pituitary-specific factor interacts with an upstream promoter element in the rat growth hormone gene. Mol. Endocrinol. 1:90-96.
  • Chatelain, A., J. P. Dupouy, and M. P. Dubois. 1979. Ontogenesis of cells producing polypeptide hormones (ACTH, MSH, LPH, GH, prolactin) in the fetal hypophysis of the rat: influence of the hypothalamus. Cell Tissue Res. 196:409-427.
  • de Wet, J. R., K. B. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
  • Distel, R. J., and B. M. Spiegelman. 1990. Protooncogene c-fos as a transcription factor. Adv. Cancer Res. 55:37-55.
  • Drouin, J., M. Chamberland, L. Jeannotte, and M. Nemer. 1985. Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 193:54-58.
  • Drouin, J., M. Nemer, J. Charron, J.-P. Gagner, L. Jeannotte, Y. L. Sun, M. Therrien, and Y. Tremblay. 1989. Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids. Genome 31:510-519.
  • Drouin, J., Y. L. Sun, and M. Nemer. 1990. Regulatory elements of the pro-opiomelanocortin gene: pituitary specificity and glucocorticoid repression. Trends Endocrinol. Metab. 2:219-225.
  • Drouin, J., M. A. Trifiro, R. K. Plante, M. Nemer, P. Eriksson, and O. Wrange. 1989. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol. Cell. Biol. 9:5305-5314.
  • Galas, D. J., and A. Schmitz. 1978. DNase footprinting: a simple method for detection of protein-DNA binding specificity. Nucleic Acids Res. 5:3157-3170.
  • Ghosh, D. 1990. A relational database of transcription factors. Nucleic Acids Res. 18:1749-1756.
  • Hwung, Y. P., L. H. Wang, S. Y. Tsai, and M. J. Tsai. 1988. Differential binding of the chicken ovalbumin upstream promoter (COUP) transcription factor to two different promoters. J. Biol. Chem. 263:13470-13474.
  • Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51:251-260.
  • Ingraham, H. A., R. Chen, H. J. Mangalam, H. P. Elsholtz, S. E. Flynn, C. R. Lin, D. M. Simmons, L. Swanson, and M. G. Rosenfeld. 1988. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519-529.
  • Jeannotte, L., M. A. Trifiro, R. K. Plante, M. Chamberland, and J. Drouin. 1987. Tissue-specific activity of the pro-opiomelanocortin gene promoter. Mol. Cell. Biol. 7:4058-4064.
  • LeFèvre, C., M. Imagawa, S. Dana, J. Grindlay, M. Bodner, and M. Karin. 1987. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J. 6:871-981.
  • Lichtsteiner, S., J. Wuarin, and V. Schibler. 1987. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell 51:963-973.
  • Lugo, D. I., J. L. Roberts, and J. E. Pintar. 1989. Analysis of proopiomelanocortin gene expression during prenatal development of the rat pituitary gland. Mol. Endocrinol. 3:1313-1324.
  • Mangalam, H. J., V. R. Albert, H. A. Ingraham, M. Kapiloff, L. Wilson, C. Nelson, H. Elsholtz, and M. G. Rosenfeld. 1989. A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev. 3:946-958.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Nelson, C., V. R. Albert, H. P. Elsholtz, L. I. W. Lu, and M. G. Rosenfeld. 1988. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239:1400-1405.
  • Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-456.
  • Potter, H., L. Weir, and P. Leder. 1984. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81:7161-7165.
  • Riegel, A. T., J. Remenick, R. G. Wolford, D. S. Berard, and G. L. Hager. 1990. A novel transcriptional activator (PO-B) binds between the TATA box and cap site of the pro-opiomelanocortin gene. Nucleic Acids Res. 18:4513-4521.
  • Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
  • Selden, R. F., K. Burke-Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. 1986. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179.
  • Simmons, D. M., J. W. Voss, H. A. Ingraham, J. M. Holloway, R. S. Broide, M. G. Rosenfeld, and L. W. Swanson. 1990. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 4:695-711.
  • Smale, S. T., and D. Baltimore. 1989. The “initiator” as a transcription control element. Cell 57:103-113.
  • Sun, Y. L., M. Therrien, M. Nguyen, and J. Drouin. Submitted for publication.
  • Taylor, J. W., J. Ott, and F. Eckstein. 1985. The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothionate-modified DNA. Nucleic Acids Res. 13:8756-8785.
  • Tremblay, Y., I. Tretjakoff, A. Peterson, T. Antakly, C. X. Zhang, and J. Drouin. 1988. Pituitary-specific expression and glucocorticoid regulation of a pro-opiomelanocortin (POMC) fusion gene in transgenic mice. Proc. Natl. Acad. Sci. USA 85:8890-8894.
  • Vogt, P. K., and T. J. Bos. 1990. Jun: oncogene and transcription factor. Adv. Cancer Res. 55:1-35.
  • Wang, L.-H., S. Y. Tsai, I. Sagami, M. J. Tsai, and B. W. O’Malley. 1987. Purification and characterization of chicken ovalbumin upstream promoter transcription factor from Hela cells. J. Biol. Chem. 259:7850-7856.
  • Watanabe, Y. G., and S. Daikoku. 1979. An immunohistochemical study on the cytogenesis of adenohypophysial cells in fetal rats. Dev. Biol. 68:557-567.
  • Weiher, H., M. König, and P. Gruss. 1983. Multiple point mutations affecting the simian virus 40 enhancer. Science 219:626-631.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.